Presentation is loading. Please wait.

Presentation is loading. Please wait.

Hervé Marion, DVM VICH Secretariat

Published byPatrycja Czyż Modified over 5 years ago

Similar presentations

Presentation on theme: "Hervé Marion, DVM VICH Secretariat"— Presentation transcript:

1 Hervé Marion, DVM VICH Secretariat
Report by the VICH Steering Committee on issues raised by Forum members during the 8th Outreach Forum meeting Hervé Marion, DVM VICH Secretariat 9th VICH Outreach Forum Meeting Tokyo, March 2017

2 Extension of time for group discussions
8th Forum: Usefulness of breakout in small group discussions with VOF and SC members Extension of time for group discussions Day 1: Breakout session 1 = Small groups Day 2: Breakout session 2 = General tour de table discussion

3 8th Forum: Individual VICH Outreach Forum member questions
Group discussions 8th Forum: Individual VICH Outreach Forum member questions Breakout session 1 (Tuesday from to 17.15) Regional organisation and collaborating systems (Presentations by CAMEVET and ASEAN) VICH SC and observers experience - The EU organisation in place Discussion on how to develop Regional organisation and collaborating systems

4 Group discussions Breakout session 2 (Wednesday from to10.30) Pharmacovigilance (Introduction by the FDA) Tour de table open discussion & questions on: Needs of the VOF members Global electronic systems Sharing the Pharmacovigilance data

5 Proposed new topics Report from SC discussions on proposed new topics from VOF AMR – how VICH GL 27 is used in Japan - surveillance connected to efficacy Alternatives to Antimicrobial: processes for regulation to control autogenous vaccine in Thailand

6 Specific Issues 8th Forum: Specific issues Vaccines (USDA) Vaccines stability Immunogenicity studies Biologicals (JMAFF) Review of the VICH GLs on Biologicals

7 Specific Issues New VOF members Registration systems Nigeria Zimbabwe Feed-back of the training Workshops held in Brunei

8 VOF participation in EWGs
New EWG for combination product GLs Chaired by China – Dr Xu Expert from Argentina VOF experts are also participating in the development of: MRK GL: Residues in Honey (Argentina) Quality GL: Stability Testing of New Veterinary Drug Substances and Medicinal Products in Climatic Zones III and IV (Camevet, China & Morocco)

9 VICH SC members ongoing reflexion Current meeting frequency = 9 months
VOF meetings freqency VICH SC members ongoing reflexion Current meeting frequency = 9 months New proposal: 12 months’ cycle for VICH SC and VOF meetings

10 GETTING IT TOGETHER IN AFRICA
Next Public Event VICH 6 CONFERENCE GETTING IT TOGETHER IN AFRICA CAPE Town, SA 27 & 28 February 2019

11 VICH website Outreach Forum members only webpage (

12 The VICH public website (http://www.vichsec.org)
12 12

13 THANK YOU FOR YOUR ATTENTION !

Download ppt "Hervé Marion, DVM VICH Secretariat"

Similar presentations

OIE First Global Conference on Veterinary Legislation 1 Control of Veterinary Products: The Need for Global Standards Merton V. Smith, Ph.D., J.D. Director,

OIE First Global Conference on Veterinary Legislation 1 Control of Veterinary Products: The Need for Global Standards Merton V. Smith, Ph.D., J.D. Director,
Activities in 2006 and 2007 OIE Tokyo SEAFMD Sub-Commission Meeting Siem Reap, Cambodia 12-16 March 2007 T. Fujita OIE Regional Representative for Asia.

Activities in 2006 and 2007 OIE Tokyo SEAFMD Sub-Commission Meeting Siem Reap, Cambodia March 2007 T. Fujita OIE Regional Representative for Asia.
Need for integrated and sustainable regulatory surveillance of veterinary biologicals Gábor Kulcsár VBRN Advisory Group Meeting of HMA, Visegrád, 28 April.

Need for integrated and sustainable regulatory surveillance of veterinary biologicals Gábor Kulcsár VBRN Advisory Group Meeting of HMA, Visegrád, 28 April.
On ICH Feb. 13, 2013 Toshi Tominaga Ph. D. Food and Drug Evaluation Center, Osaka City Univ. Hospital International Regulatory Harmonization Amid Globalization.

On ICH Feb. 13, 2013 Toshi Tominaga Ph. D. Food and Drug Evaluation Center, Osaka City Univ. Hospital International Regulatory Harmonization Amid Globalization.
DETERMINATION OF RELATED SUBSTANCES & IMPURITIES IN DRUGS BY ICH GUIDE LINES BY M.PAUL RICHARDS.

DETERMINATION OF RELATED SUBSTANCES & IMPURITIES IN DRUGS BY ICH GUIDE LINES BY M.PAUL RICHARDS.
*The views expressed in this presentation are those of the presenter’s and do not necessarily represent the views of the U.S. Food and Drug Administration.

*The views expressed in this presentation are those of the presenter’s and do not necessarily represent the views of the U.S. Food and Drug Administration.
Dr. Marion Tobler WP4 Leader Annual Meeting 7./8. March 2012 Tallinn 1 ENT Annual meeting report 2012.

Dr. Marion Tobler WP4 Leader Annual Meeting 7./8. March 2012 Tallinn 1 ENT Annual meeting report 2012.
EC actions against the rising threats from Antimicrobial Resistance

EC actions against the rising threats from Antimicrobial Resistance
FDA Public Meeting Preparation for the ICH Meetings in Tokyo, Japan, Including Progress on the Common Technical Document and Possibilities for New Topics.

FDA Public Meeting Preparation for the ICH Meetings in Tokyo, Japan, Including Progress on the Common Technical Document and Possibilities for New Topics.
Role of VICH and VICH guidelines in the approval process for veterinary medicinal products David Mackay, European Medicines Agency VICH Workshop – Dar.

Role of VICH and VICH guidelines in the approval process for veterinary medicinal products David Mackay, European Medicines Agency VICH Workshop – Dar.
Application of VICH GLs – extract from group discussion General: VICH GLs do not prescribe the data package to be submitted for registration, they merely.

Application of VICH GLs – extract from group discussion General: VICH GLs do not prescribe the data package to be submitted for registration, they merely.
1 Outcome of the 4 th Global Animal Health Conference (GAHC) 24 -25 June 2015 Bettye K. Walters, DVM US Food and Drug Administration

1 Outcome of the 4 th Global Animal Health Conference (GAHC) June 2015 Bettye K. Walters, DVM US Food and Drug Administration
JMAFF (Chair of Biologicals Quality Monitoring EWG)

JMAFF (Chair of Biologicals Quality Monitoring EWG)
Development and Harmonization VICH5 November 29, 2015 VICH Electronic Standards Implementation Margarita Brown, DVM MS, Chair FDA Center for Veterinary.

Development and Harmonization VICH5 November 29, 2015 VICH Electronic Standards Implementation Margarita Brown, DVM MS, Chair FDA Center for Veterinary.
VICH General Principles and current update of VICH Outreach Forum activity 1.

VICH General Principles and current update of VICH Outreach Forum activity 1.
VICH Training Strategy Steven D. Vaughn, DVM Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine U.S. Food and Drug Administration.

VICH Training Strategy Steven D. Vaughn, DVM Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine U.S. Food and Drug Administration.
Introduction to the VICH Outreach Forum Steven D. Vaughn, DVM VICH Workshop Dar Es Salaam, Tanzania – June 24, 2015.

Introduction to the VICH Outreach Forum Steven D. Vaughn, DVM VICH Workshop Dar Es Salaam, Tanzania – June 24, 2015.
Industry: trends, concerns hopes and ideas VICH5 Conference Carel du Marchie Sarvaas, Executive Director October 2015.

Industry: trends, concerns hopes and ideas VICH5 Conference Carel du Marchie Sarvaas, Executive Director October 2015.
-What is VICH, History and Objectives Hervé MARION, DVM VICH Secretariat.

-What is VICH, History and Objectives Hervé MARION, DVM VICH Secretariat.
1 VICH AND VETERINARY MEDICINES AVAILABILITY VICH5 CONFERENCE, OCTOBER 2015, TOKYO VICH AND VETERINARY MEDICINES AVAILABILITY VICH5 CONFERENCE, OCTOBER.

1 VICH AND VETERINARY MEDICINES AVAILABILITY VICH5 CONFERENCE, OCTOBER 2015, TOKYO VICH AND VETERINARY MEDICINES AVAILABILITY VICH5 CONFERENCE, OCTOBER.

Similar presentations

Ads by Google